| Literature DB >> 26123494 |
Ranad Shaheen1, Agaadir Almoisheer1, Eissa Faqeih2, Zainab Babay3, Dorota Monies4, Nada Tassan4, Mohamed Abouelhoda4, Wesam Kurdi5, Elham Al Mardawi6, Mohamed M I Khalil7, Mohammed Zain Seidahmed8, Maha Alnemer5, Nada Alsahan5, Samira Sogaty9, Amal Alhashem10, Ankur Singh11, Manisha Goyal11, Seema Kapoor12, Rana Alomar1, Niema Ibrahim1, Fowzan S Alkuraya13.
Abstract
Meckel-Gruber syndrome (MKS) is a perinatally lethal disorder characterized by the triad of occipital encephalocele, polydactyly and polycystic kidneys. Typical of other disorders related to defective primary cilium (ciliopathies), MKS is genetically heterogeneous with mutations in a dozen genes to date known to cause the disease. In an ongoing effort to characterize MKS clinically and genetically, we implemented a gene panel and next-generation sequencing approach to identify the causal mutation in 25 MKS families. Of the three families that did not harbor an identifiable causal mutation by this approach, two mapped to a novel disease locus in which whole-exome sequencing revealed the likely causal mutation as a homozygous splicing variant in TMEM107, which we confirm leads to aberrant splicing and nonsense-mediated decay. TMEM107 had been independently identified in two mouse models as a cilia-related protein and mutant mice display typical ciliopathy phenotypes. Our analysis of patient fibroblasts shows marked ciliogenesis defect with an accompanying perturbation of sonic hedgehog signaling, highly concordant with the cellular phenotype in Tmem107 mutants. This study shows that known MKS loci account for the overwhelming majority of MKS cases but additional loci exist including MKS13 caused by TMEM107 mutation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26123494 DOI: 10.1093/hmg/ddv242
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150